home / stock / blrx / blrx short
Short Information | BioLineRx Ltd. (NASDAQ:BLRX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,526,262 |
Total Actual Volume | 5,334,743 |
Short Trends | |
---|---|
Cover Days | 14 |
Short Days | 1 |
No Change Days | 5 |
Averages | |
---|---|
Average Short Volume | 76,313 |
Average Short Percentage | 29.44% |
Is there a BLRX Short Squeeze or Breakout about to happen?
See the BLRX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $0.56 | $0.532 | $0.57495 | $0.5228 | 393,942 | 112,191 | 28.48% |
07-01-2024 | $0.566 | $0.56 | $0.583879 | $0.5509 | 150,671 | 37,183 | 24.68% |
06-28-2024 | $0.5629 | $0.5699 | $0.5797 | $0.5528 | 276,846 | 97,908 | 35.37% |
06-27-2024 | $0.5659 | $0.57 | $0.6 | $0.56 | 103,776 | 33,833 | 32.6% |
06-26-2024 | $0.5717 | $0.561 | $0.5858 | $0.555 | 306,332 | 68,928 | 22.5% |
06-25-2024 | $0.62 | $0.5751 | $0.623 | $0.571 | 383,763 | 139,798 | 36.43% |
06-24-2024 | $0.59 | $0.61 | $0.63 | $0.59 | 414,565 | 75,346 | 18.17% |
06-21-2024 | $0.6 | $0.59 | $0.605 | $0.576 | 271,799 | 106,729 | 39.27% |
06-20-2024 | $0.6196 | $0.59 | $0.6196 | $0.5827 | 422,832 | 151,771 | 35.89% |
06-18-2024 | $0.65 | $0.6162 | $0.659899 | $0.6101 | 261,332 | 73,247 | 28.03% |
06-17-2024 | $0.659 | $0.64 | $0.66 | $0.63 | 196,030 | 42,107 | 21.48% |
06-14-2024 | $0.652 | $0.6679 | $0.6798 | $0.651407 | 239,169 | 121,385 | 50.75% |
06-13-2024 | $0.67 | $0.68 | $0.689 | $0.6508 | 205,004 | 56,177 | 27.4% |
06-12-2024 | $0.679 | $0.6546 | $0.679 | $0.641 | 363,380 | 46,654 | 12.84% |
06-11-2024 | $0.6476 | $0.67985 | $0.6799 | $0.6351 | 94,318 | 40,252 | 42.68% |
06-10-2024 | $0.68 | $0.6646 | $0.698 | $0.63 | 298,960 | 96,902 | 32.41% |
06-07-2024 | $0.71 | $0.6576 | $0.7389 | $0.655 | 267,897 | 66,368 | 24.77% |
06-06-2024 | $0.7125 | $0.6965 | $0.75 | $0.691 | 310,534 | 58,115 | 18.71% |
06-05-2024 | $0.7 | $0.724 | $0.7303 | $0.6902 | 118,388 | 36,847 | 31.12% |
06-04-2024 | $0.73 | $0.69875 | $0.75 | $0.681 | 255,205 | 64,521 | 25.28% |
News, Short Squeeze, Breakout and More Instantly...
BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD) PR Newswire - Investigator-initiated study in...
Orkla ASA ADR (ORKLY) is expected to report for Q1 2024 Cosmos Health Inc. (COSM) is expected to report $-0.14 for Q1 2024 Basilea Pharmaceutica AG Registered Shares (BPMUF) is expected to report for Q1 2024 DCC Plc (DCCPF) is expected to report for Q4 2024 Datatec Ltd ADR (DTTLY)...
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer (PDAC) at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting PR Newswire New analysis of biopsy samples demonstrate...